No analyst has come out to opine on the disparity between price targets and the market price. It is a little odd. Could the $15 PPS be really a reflection of expectation that TEVA may get approved? I would think that there would be some premium built into the stock in light of approval (notwithstanding possible TEVA approval), but there is absolutely none. Several analysts have already come out and spoken about the potential that MNTA would be acquired, yet the stock continues to drift below pre-approval levels. Hmmmm .....
Market Data 
Markets 
AI
